Effects of Pes Planus on Gait at Different Inclines (NCT07155577) | Clinical Trial Compass
CompletedNot Applicable
Effects of Pes Planus on Gait at Different Inclines
Turkey (Türkiye)30 participantsStarted 2025-07-01
Plain-language summary
This study aims to investigate the effects of pes planus deformity on gait spatiotemporal parameters and pelvic kinematics during walking on different inclines. Participants will include healthy adults aged 18-35 years with flexible bilateral pes planus and normal body mass index. Pes planus severity will be evaluated using the Jack's toe-raise test and the navicular drop test. Gait parameters such as walking speed, cadence, stride length, stance and swing phase percentages, gait cycle duration, as well as pelvic tilt, obliquity, and rotation symmetry will be measured using the BTS-G wireless sensor system. Assessments will be performed on both flat and inclined treadmill conditions. The findings are expected to provide new insights into the biomechanical adaptations of pes planus during walking and contribute to the development of an individualized rehabilitation protocol.
Who can participate
Age range
18 Years – 35 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria: \*\*Pes Planus Group
* Age 18-35 years
* Normal BMI
* Bilateral, asymptomatic flexible pes planus
* Navicular drop ≥10 mm (both feet)
* Willing and able to provide informed consent and complete the procedure.
\*\*Healthy Control Group
* Age 18-35 years
* Normal BMI
* No pes planus deformity; otherwise healthy and able to complete procedures
Exclusion Criteria:\*\* both groups
* Use of orthotics/insoles
* Musculoskeletal disorders affecting gait (other than pes planus in the case group)
* Lower extremity injury or surgery within the last 6 months
* Chronic ankle instability
* Any treatment related to the lower extremity/pes planus within the last 6 months
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.